⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1660 | 1.00 | — | — | |
| SCHEMBL1659 | 1.00 | — | — | |
| SCHEMBL3798436 | 0.71 | — | — | |
| SCHEMBL7670833 | 0.71 | — | — | |
| SCHEMBL7670830 | 0.71 | — | — | |
| SCHEMBL8829614 | 0.69 | — | — | |
| SCHEMBL9615377 | 0.69 | — | — | |
| SCHEMBL11451075 | 0.69 | — | — | |
| SCHEMBL6578754 | 0.69 | — | — | |
| SCHEMBL725434 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630697-A1 | SINGLE COMPONENT EPOXY RESIN CEMENT MORTAR | Sika Technology AG (CH) | 2020-04-08 | — | — | EP | claimed |
| CN-110662724-A | Single-component epoxy resin cement mortar | SIKA技术股份公司 | 2020-01-07 | — | — | CN | claimed |
| EP-2900645-B1 | HERBICIDAL AND FUNGICIDAL 3-PHENYLISOXAZOLIN DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2019-08-21 | — | — | EP | claimed |
| WO-2018220133-A1 | SINGLE COMPONENT EPOXY RESIN CEMENT MORTAR | SIKA TECHNOLOGY AG (CH) | 2018-12-06 | — | — | WO | claimed |
| US-20150245615-A1 | 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION | BAYER CROPSCIENCE AG (DE) | 2015-09-03 | — | — | US | claimed |
| EP-0439096-B1 | Improvements in or relating to beta lactam production | BIOCHEMIE GMBH (AT) | 2003-12-17 | — | — | EP | claimed |
| US-11643363-B2 | Single component epoxy resin cement mortar | SIKA TECHNOLOGY AG (CH) | 2023-05-09 | — | — | US | disclosed |
| EP-3630697-B1 | SINGLE-COMPONENT EPOXY RESIN CEMENT MORTAR | SIKA TECH AG (CH) | 2023-01-25 | — | — | EP | disclosed |
| EP-2464623-B1 | THE RING OPENING OF LACTONES AND LACTAMS | NOVARTIS AG (CH) | 2020-11-04 | — | — | EP | disclosed |
| US-20200123056-A1 | SINGLE COMPONENT EPOXY RESIN CEMENT MORTAR | SIKA TECHNOLOGY AG (CH) | 2020-04-23 | — | — | US | disclosed |
| EP-3630697-A1 | SINGLE COMPONENT EPOXY RESIN CEMENT MORTAR | Sika Technology AG (CH) | 2020-04-08 | — | — | EP | disclosed |
| CN-110662724-A | Single-component epoxy resin cement mortar | SIKA技术股份公司 | 2020-01-07 | — | — | CN | disclosed |
| EP-2900645-B1 | HERBICIDAL AND FUNGICIDAL 3-PHENYLISOXAZOLIN DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2019-08-21 | — | — | EP | disclosed |
| EP-0092830-A2 | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application | CIBA-GEIGY AG (CH) | 1983-11-02 | — | — | EP | disclosed |
| US-4406889-A | IMMUNOLOGY, PEPTIDES | CIBA-GEIGY CORPORATION (US) | 1983-09-27 | — | — | US | disclosed |
| EP-0059683-A2 | 7-Acylamido-3-cephem-4-carboxylic acids, process for their preparation, pharmaceutical compositions containing them and their use | CIBA-GEIGY AG (CH) | 1982-09-08 | — | — | EP | disclosed |
| EP-0058373-A1 | Substituted aliphatic secondary amines and their salts, pharmaceutical compositions containing them and their use | CIBA-GEIGY AG (CH) | 1982-08-25 | — | — | EP | disclosed |
| EP-0047977-A2 | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their use | CIBA-GEIGY AG (CH) | 1982-03-24 | — | — | EP | disclosed |
| EP-0041047-A2 | Dioxide compounds, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1981-12-02 | — | — | EP | disclosed |
| EP-0031794-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1981-07-08 | — | — | EP | disclosed |